2025 annual financial data

Cardiol Therapeutics 2025 Operating margin

Cardiol Therapeutics 2025 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -34,316,296 CAD and net income was -33,818,874 CAD.
Operating cash flow was -23,854,650 CAD.

Get free Cardiol Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 CAD
Operating income
-34,316,296 CAD
Net income
-33,818,874 CAD
Operating cash flow
-23,854,650 CAD